The SURPASS-2 trial (Fras et al., 2021, New England Journal of Medicine) provided the first head-to-head comparison of Tirzepatide against semaglutide 1mg in adults with type 2 diabetes
Always price your maintenance dose, not the starter, before deciding
Force Factor Super GLP-1 Support does not contain GLP-1 or synthetic GLP-1 and is not designed to replace GLP-1 medication. Consult a healthcare professional before discontinuing use of GLP-1 medication. *In a clinical study by Ribeiro et al. (2019), adults with elevated blood sugar levels taking 200mg of Eriomin per day saw a significant improvement of 15.6% in GLP-1 levels by week 12, compared to a 0.2% increase in the placebo group. **In a clinical study by Kaats et al. (1996), subjects who took Chromax Chromium Picolinate showed an improvement in body composition scores, percent body fat, and weight compared to placebo, in conjunction with a regular diet and exercise program. All ingredient amounts listed are per serving. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease
Part V: The Regulatory Exclusivity Stack Two Systems, One Commercial Runway Patent protection and regulatory exclusivity are legally independent systems that operate in parallel
8 Some have argued that such off-label use deprives patients with T2D of essential treatments
